re: markfnhell and noncondom wearer Independent research...

re: markfnhell and noncondom wearer Independent research estimates the global market for animal health products and treatments (all species) at US$17.9 billion. The market for disease treatment, prevention and control together with ‘productivity enhancement products’ in poultry and pigs is valued at US$6.6 billion per annum. Imugene’s current products apply to segments of this market valued at over US$3 billion pa.

Three major products segments dominate the global pig and poultry markets:

Medicinal feed additives – primarily antibiotics
Nutritional feed additives - vitamins, mineral and enzyme supplements
Biologicals / Anti-Infectives – vaccines and non-chemical products of organic origin
Together, the medicinal feed additives and nutritional feed additives comprise in excess of 60% of today’s worldwide health products market for both the pig and poultry industries.

The balance of each market is split between the pharmaceutical anti-infectives and the biological products (vaccines).

The global market for biological products is projected to grow substantially over the next 5 years while at the same time medicinal feed additives are projected to significantly reduce due to regulatory and consumer pressure.

The Imugene products are classified as biological products but will compete with and capture significant market share from the existing biologicals and medicinal feed additives market, as well as potentially opening up a whole new market segment.